Clinical trials recruiting for Tuberous Sclerosis Complex (TSC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Exemestane 25 MG | 1 |
| SVG103 | 1 |
| Sapu003 | 1 |
| YCJ-01 Full Spectrum cannbis Extract | 1 |
Self-screener
Recruiting trials
- Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis
- Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
- Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
- Sapu003 in Advanced mTOR-sensitive Solid Tumors
- Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)
Related conditions
Trials recruiting for Tuberous Sclerosis Complex (TSC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Tuberous Sclerosis Complex (TSC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.